Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
17.00
Dollar change
-1.08
Percentage change
-5.97
%
IndexRUT P/E- EPS (ttm)-1.01 Insider Own13.68% Shs Outstand53.68M Perf Week4.49%
Market Cap914.27M Forward P/E- EPS next Y-4.28 Insider Trans0.00% Shs Float46.42M Perf Month1.92%
Income-50.92M PEG- EPS next Q-1.18 Inst Own93.00% Short Float14.62% Perf Quarter-19.62%
Sales217.25M P/S4.21 EPS this Y15.73% Inst Trans-3.92% Short Ratio14.85 Perf Half Y-22.87%
Book/sh10.82 P/B1.57 EPS next Y-84.10% ROA-7.45% Short Interest6.79M Perf Year-53.37%
Cash/sh10.49 P/C1.62 EPS next 5Y34.07% ROE-8.75% 52W Range15.30 - 41.54 Perf YTD-53.22%
Dividend Est.- P/FCF- EPS past 5Y6.83% ROI-8.61% 52W High-59.08% Beta0.15
Dividend TTM- Quick Ratio12.54 Sales past 5Y4680.14% Gross Margin91.54% 52W Low11.11% ATR (14)1.01
Dividend Ex-Date- Current Ratio12.54 EPS Y/Y TTM65.67% Oper. Margin-42.05% RSI (14)45.10 Volatility8.07% 4.99%
Employees173 Debt/Eq0.02 Sales Y/Y TTM276.98% Profit Margin-23.44% Recom1.50 Target Price61.14
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q218.24% Payout- Rel Volume1.43 Prev Close18.08
Sales Surprise1130.59% EPS Surprise215.21% Sales Q/Q3184.75% EarningsAug 08 AMC Avg Volume456.79K Price17.00
SMA200.51% SMA50-11.26% SMA200-25.09% Trades Volume651,439 Change-5.97%
Date Action Analyst Rating Change Price Target Change
Jan-30-24Downgrade BofA Securities Buy → Neutral $68 → $38
Dec-12-23Initiated Deutsche Bank Buy $62
Apr-24-23Initiated SVB Securities Outperform $80
Jan-27-23Initiated Piper Sandler Overweight $94
Nov-04-22Downgrade RBC Capital Mkts Outperform → Sector Perform $52 → $55
Sep-28-22Upgrade BofA Securities Neutral → Buy
Nov-19-21Initiated JMP Securities Mkt Outperform $77
Jun-18-21Upgrade BofA Securities Underperform → Neutral $12 → $49
Jun-08-21Reiterated Oppenheimer Outperform $45 → $54
May-26-21Initiated Citigroup Buy $39
Oct-29-24 12:00PM
04:48AM
Oct-18-24 03:01PM
Sep-27-24 04:05PM
Aug-29-24 04:05PM
12:00PM Loading…
Aug-19-24 12:00PM
Aug-18-24 12:28AM
Aug-17-24 08:22AM
Aug-09-24 09:16AM
Aug-08-24 06:40PM
05:33PM
04:05PM
Aug-01-24 04:05PM
Jul-25-24 10:02AM
Jun-24-24 08:48AM
04:07PM Loading…
Jun-11-24 04:07PM
12:20PM
Jun-07-24 11:30AM
May-29-24 10:26AM
08:46AM
May-28-24 04:05PM
May-09-24 11:52AM
May-08-24 10:56PM
06:10PM
05:14PM
04:05PM
May-01-24 04:05PM
Apr-25-24 10:01AM
Apr-15-24 04:05PM
Mar-28-24 08:00AM
04:05PM Loading…
Mar-05-24 04:05PM
Mar-04-24 04:05PM
Feb-21-24 04:05PM
Feb-16-24 01:33PM
10:33AM
Feb-15-24 04:50PM
04:48PM
04:05PM
Feb-08-24 04:05PM
Jan-24-24 11:02PM
Jan-10-24 12:06PM
05:38AM
Jan-08-24 08:30AM
Dec-21-23 09:01AM
Dec-17-23 05:41AM
Dec-01-23 11:05AM
Nov-29-23 08:35AM
Nov-20-23 06:00AM
Nov-17-23 01:35PM
08:15AM
Nov-03-23 11:34AM
Nov-02-23 07:03PM
06:25PM
05:24PM
04:05PM
Oct-30-23 10:00AM
Oct-26-23 04:09PM
04:05PM
10:02AM
05:02AM
Oct-18-23 11:20AM
Oct-17-23 07:57AM
Oct-16-23 11:54AM
11:42AM
Oct-12-23 05:01AM
Oct-07-23 03:33PM
Oct-05-23 09:01AM
Sep-28-23 05:01AM
Sep-19-23 09:01PM
Sep-14-23 01:32PM
Sep-07-23 12:00PM
Aug-31-23 04:05PM
Aug-04-23 09:13AM
Aug-03-23 05:55PM
04:49PM
04:05PM
Aug-02-23 07:57AM
Jul-27-23 04:05PM
Jul-18-23 05:36PM
05:36PM
11:30AM
Jul-17-23 08:35AM
Jul-13-23 09:22AM
Jul-11-23 04:05PM
08:59AM
Jul-10-23 04:10PM
Jul-07-23 09:51AM
Jun-27-23 04:05PM
Jun-12-23 09:25AM
Jun-08-23 12:41PM
Jun-02-23 04:05PM
May-16-23 04:05PM
May-10-23 06:13AM
May-05-23 12:27PM
May-04-23 06:45PM
05:39PM
04:05PM
Apr-27-23 04:05PM
10:02AM
Apr-24-23 04:05PM
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walker Karin LChief Accounting OfficerJan 24 '24Option Exercise13.535,00067,6505,000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerJan 24 '24Sale34.005,000170,0000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerDec 20 '23Option Exercise13.535,00067,6505,000Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerDec 20 '23Sale37.195,000185,9520Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerNov 30 '23Option Exercise13.535,00067,6505,000Nov 30 06:24 PM
Walker Karin LChief Accounting OfficerNov 30 '23Sale34.005,000170,0000Nov 30 06:24 PM